Press Releases

NeuraMetrix Press-Releases

April 15, 2021

NeuraMetrix’ Digital Brain Health Biomarker Selected for Participation in Boston University’s Precision Brain Health Initiative

NeuraMetrix... today announced that Boston University (BU) School of Medicine has selected NeuraMetrix’ breakthrough digital biomarker, which detect and monitor brain diseases, to participate in their Precision Brain Health Initiative funded by the American Heart Association in collaboration with global philanthropist Bill Gates.​​​​​​​

​​​​​​​Read More

April 8, 2021

NeuraMetrix and the Huntington Center Ulm Publish a Research Article on Monitoring Huntington Disease

NeuraMetrix... and Huntington Center Ulm, Department of Neurology, Ulm University, Germany have jointly published a research article: “Monitoring the Phenotype in Huntington Disease by Analysis of Keyboard Typing During Real Life Computer Use” in the Journal of Huntington's Disease.

​​​​​​​Read More

January 27, 2021

NeuraMetrix and bioaccess™ Sign Agreement to Commercialize NeuraMetrix’ Breakthrough Mental and Brain Health Technology in Latin America

NeuraMetrix... and bioaccess™, an Orlando-based contract research organization (CRO) and market access consulting firm dedicated to helping innovative Medtech companies succeed with their market expansion plans in Latin America, announced that they have entered into a partnership agreement to conduct clinical research and commercialize the digital brain health monitoring biomarker based on typing cadence in Latin America. 

​​​​​​​Read More

July 23, 2019

N-Strategy Consulting Services to Accelerate and Invest In NeuraMetrix Asia-pacific Market Entry

NeuraMetrix, Inc. and N-Strategy Consulting Services [NSCS] have entered into an agreement where NSCS, with its founder and CEO Nathanael Noiraud, will accelerate and invest in NeuraMetrix’s Asia-Pacific market entry.

​​​​​​​Read More

January 8, 2019

FDA Grants Breakthrough Device Designation to NeuraMetrix

37th Annual J.P. Morgan Healthcare Conference in San Francisco, California: The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the NeuraMetrix digital brain health monitoring biomarker.